E Point Perfect – Interesting and beneficial content
Law \ Legal

Pharmaceutical Manufacturer Agrees to $900M False Claims Act Settlement to Resolve Kickback Claims


On July 20, Biogen Inc. agreed to pay $900 million to settle claims the company violated the False Claims Act by allegedly paying improper consulting and speaker fees and providing lavish meals and entertainment to medical providers to induce them to prescribe the multiple sclerosis drugs it manufactures.

Read on for details about this unusually large settlement, which highlights the risks associated with pharmaceutical and device manufacturers hiring providers as consultants and conducting speaker programs.


Source link

Related posts

rish Legislature Publishes Draft Amendments Legalizing Third-Party Funding for International Arbitration

Breach of Fiduciary Duty in Estate Planning and Administration: What You Can Do


Memories of Ft. Myers and The Purpose of Insurance

Legal Malpractice Claim? Yes Fraud? No

Medical: Additional OT assessment.